Introduction {#s1}
============

*Brucella melitensis* is a ubiquitous and common pathogen of goats and sheep worldwide (Seleem et al., [@B37]; Moreno, [@B26]). This pathogen was first identified in Malta by David Bruce in 1887, with subsequent discovery of the role of contaminated goat\'s milk for brucellosis infections in humans by Themistocles Zammit in 1905 (Vassallo, [@B44]; Wyatt, [@B49]). Despite apparent host specificity of *B. melitensis* to caprines, this bacterium also infects camels (Abbas and Agab, [@B1]; Gwida et al., [@B12]; Sprague et al., [@B39]; Wernery, [@B45]). Arabian camels (*Camelus dromedarius*) occur throughout the deserts of North Africa and across the Middle East to North India, a region where they are critical for meat, milk, leather, wool and transport (Wilson, [@B48]). Camel brucellosis was first reported in 1931 and has since been found in all camel-keeping countries in this region but are particularly well documented for infected herds from Africa and the Arabian Peninsula (Gwida et al., [@B12]).

Camels are not a primary host for *Brucella* spp. but infections with *B. melitensis* occur due to the co-mingling of camels and ruminant livestock (Sprague et al., [@B39]). In fact, among the highest prevalence rates in camels have been documented when camel herds are intermixed with ruminants (Musa et al., [@B27]). Despite this cross-species transmission, epidemiological links between brucellosis in camels and other livestock are poorly understood. Prevalence rates of brucellosis in camels vary widely based on several factors, especially animal husbandry practices (Gwida et al., [@B12]). Camels can also be infected with *B. abortus*, likely due to the commingling of camel herds with infected cattle (Sprague et al., [@B39]). Thus, brucellosis prevalence in camels is complex and the role of infections in the primary caprine and bovine hosts must be considered. The pathology of brucellosis infection in camels is poorly known as well. Consistent with findings from other livestock, the bacteria appear to localize in reproductive tissues, lymph nodes, and spleen, causing inflammation, edema, and necrosis (Wernery, [@B45]). Infection of pregnant camels can result in placental and fetal pathologies resulting in abortion (Narnaware et al., [@B28]). As with brucellosis in other animals, these abortion events likely disseminate the bacteria broadly and allow for transmission to other livestock and to animal handlers. Not surprisingly, the disease is prevalent in Bedouin in Oman (Scrimgeour et al., [@B36]).

Several serological tests, such as Rose Bengal, tube and serum agglutination tests and ELISAs that have been optimized for testing cattle are used to determine *Brucella* seroprevalence in camels (Gwida et al., [@B12]), but epidemiological investigations often stop at this point. Furthermore, the lack of validated serological tests that detect *Brucella* infection in camels pose a challenge to definitive diagnosis. A combination of real-time PCR and serological tests provides a solution to many of the diagnostic challenges (Gwida et al., [@B13]). To determine the causative species, bacterial culturing from milk, blood or tissues of infected animals is performed to recover bacterial isolates. For *B. melitensis*, subsequent testing is required to distinguish the three biovars that are traditionally assessed in characterizing this species.

Brucellosis is a public health concern throughout the Greater Middle East (Pappas and Memish, [@B31]) and has been considered "hyperendemic" in Saudi Arabia with \~8,000 reported cases per annum (Memish and Mah, [@B25]). Comprehensive reporting of the disease throughout the region has been elusive due to limited public health infrastructure in many countries. Refai ([@B34]) documented that brucellosis was ubiquitous throughout the Near East, with highest human incidence in Saudi Arabia, Iran, Syria, Jordan, and Oman. In fact, Western Asia contains among the highest incidence of brucellosis globally (Pappas et al., [@B32]). Human exposure to brucellosis from camels occurs primarily from contaminated milk (Shimol et al., [@B38]; Garcell et al., [@B9]). More broadly across other animal hosts, brucellosis infections most often occur in people working in close contact with animal tissues such as slaughterhouse workers, veterinarians, and farmers (Kaufmann et al., [@B19]; Whatmore, [@B46]). Determining the genetic diversity of *B. melitensis* in camels would provide valuable information about disease dispersal and transmission among camels, goats, and sheep in endemic areas, and particularly help better understand the role of camels in human infections.

As part of a brucellosis control program, we collected animal samples from routine surveillance activities. Tissues or bodily fluids were collected and isolates of *B. melitensis* were recovered from camels, goats, sheep, and cattle in the Dhofar governorate of Oman, an area with the highest brucellosis prevalence in the country (El Tahir and Nair, [@B8]). In 1996, a brucellosis control program that implemented both vaccination and culling of infected animals was initiated in the Dhofar region. As a part of an animal disease surveillance system, the regional Brucellosis Diagnostic Lab in Salalah, Dhofar identified all *Brucella* species that were involved in animal brucellosis cases. Because *B. melitensis* isolates from this region are not well characterized, we took two approaches to assess genetic relationships. First, we placed these isolates into a global phylogeny using single nucleotide polymorphism (SNP)-based genotyping assays specific to major evolutionary lineages of *B. melitensis*. We then genotyped a subset of these samples using multilocus variable number tandem repeats analysis (MLVA), following Huynh et al. ([@B16]), to confirm their placement into well characterized clades. Our results suggest the genetic lineage of *B. melitensis* isolates in camels in Oman extends from North Africa into the Arabian Peninsula.

Materials and methods {#s2}
=====================

Aborted fetuses, placental membranes and vaginal swabs/discharge from aborted animals, and milk secretions and blood from suspected animal brucellosis cases were collected in the Dhofar governorate of southwestern Oman. Samples were handled under BSL-3 containment at the Animal Health Research Center, Ministry of Agriculture and Fisheries, Sultanate of Oman. Putative *Brucella* samples were inoculated on sheep blood agar plates together with *Brucella* selective supplement (SR 0083; Oxoid, Hampshire, UK) and 2.5% glucose. The plates were incubated at 37°C with (10%) or without CO~2~ for 7 days. Colonies were presumptively identified as *Brucella* by morphology and Gram staining and further biotyped using standard microbiological lab procedures (Alton et al., [@B5]; OIE, [@B30]). *Brucella* genus and species identification was confirmed by PCR (Hinic et al., [@B15]). Thirty-four isolates of *B. melitensis* were recovered from four animal species: camels (*n* = 15), goats (*n* = 8), cattle (*n* = 7), and sheep (*n* = 4) from 1997 to 2010 (Table [1](#T1){ref-type="table"}). These samples are stored in the *Brucella* repository of the Animal Health Research Center. Twenty-hour individual broth cultures (\~2 × 10^9^/ml) were pelleted by centrifugation (7,500 rpm) for 10 min and genomic DNA was extracted and purified using Qiagen DNeasy Blood and Tissue Kits (Hilden, Germany) following the manufacturer\'s protocol for Gram-negative bacteria.

###### 

Characteristics of 27 *Brucella melitensis* isolates collected from livestock in Dhofar governorate, Oman.

  **Year**   **Collection source**     **Animal**   **Location**   **Catalase**   **Oxidase**   **Urease**   **H~2~S prod**.   **CO~2~ req**.   **Growth on dyes**   **Phage lysis**   **Agglutination with monospecific antisera**            
  ---------- ------------------------- ------------ -------------- -------------- ------------- ------------ ----------------- ---------------- -------------------- ----------------- ---------------------------------------------- ---- --- ----
  1997       placental membrane        camel        Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1999       aborted fetus             camel        Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1999       milk                      camel        Taqah          \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1999       milk                      camel        Taqah          \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2003       fetus                     camel        Mirbat         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2004       vaginal swab/fetus        camel        Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             \+   −   \+
  2004       milk/vaginal swab         camel        Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             \+   −   \+
  2004       aborted material          camel        Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             \+   −   \+
  2004       aborted membranes         camel        Mirbat         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2004       fetal stomach             camel        Rakhyut        \+             \+            \+           −                 −                \+                   −                 \+                                             \+   −   \+
  2004       fetal stomach             camel        Dalkut         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2004       fetus                     camel        Rakhyut        \+             \+            \+           −                 −                \+                   −                 \+                                             \+   −   \+
  2005       milk                      camel        Thumrayt       \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2005       milk                      camel        Thumrayt       \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2007       stomach content fetus     camel        Muqshin        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       fetus (stomach/lungs)     sheep        Mirbat         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       fetus                     cow          Taqah          \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       fetus                     sheep        Taqah          \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       fetus                     sheep        Taqah          \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       vaginal discharge         cow          Salalah        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1997       fetus                     sheep        Mirbat         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1998       milk /vaginal discharge   cow          Unknown        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1998       milk                      cow          Unknown        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  1999       fetus                     goat         Shalim         \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2000       fetus                     cow          Unknown        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2000       vaginal discharge         cow          Unknown        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+
  2000       vaginal discharge         cow          Unknown        \+             \+            \+           −                 −                \+                   −                 \+                                             −    −   \+

*Biotyping indicated that all 27 samples were biovar 1. Seven additional B. melitensis isolates from blood samples from goats were also collected from Saham in the Al Batinah North Governorate in 2010, but were not biotyped*.

A sub-set of MLVA profiles derived from geographically diverse *B. melitensis* isolates causing human infection was generated at the U.S. Centers for Disease Control and Prevention (CDC) and used in the analysis to understand the distribution of *B. melitensis* genotypes in the region. Samples originating from Egypt with the naming designation starting with "E" were collected from an acute febrile illness surveillance study in Egypt as described by Afifi et al. ([@B2]) and a MLVA study of this sub-set of isolates is described by Tiller et al. ([@B43]). The remainder of the patient samples came from reference diagnostic specimens or were recovered from outbreak or support testing by the CDC. Samples were de-identified prior to analyses. Isolation and DNA extraction methods followed those detailed in Tiller et al. ([@B43]). Three reference strains (16 M, 63/9, Rev-1) came from the CDC strain collection but their complete culture history is not known. These strains were MLVA genotyped using the actual isolates rather than using the genome sequence. All strains were minimally passaged after collection from human or animal sources. All culture and manipulation of *Brucella* isolates were conducted in BSL-3 conditions.

To develop a *B. melitensis* SNP genotyping assay, we conducted an *in silico* analysis of 29 *B. melitensis* genomes that were then available in GenBank and generated a phylogenetic tree using Northern Arizona SNP Pipeline (NASP) (Sahl et al., [@B35]; Figure [1](#F1){ref-type="fig"}). We used default parameters for SNP calling for each genome, which included a minimum of 10X coverage at a locus, at least 90% consensus for a SNP allele, and the requirement that the SNP locus was present in all genomes (i.e., no missing data).

![SNP-based phylogenetic tree of *Brucella melitensis* using 29 genomes available at time of assay development. Numbered branches correspond to SNP-based assays for each of the corresponding lineages. Note that the *B. melitensis* lineage known as the W. Mediterranean group (includes the Ether strain), is a basal group and is not shown in this tree. Country names indicate where the isolate was identified, and due to travel and sharing of strains among labs, this is not necessarily the country of origin.](fmicb-08-02702-g0001){#F1}

Using these genome sequences, flanking regions were aligned using Sequencher 5.0, and Melt-MAMA (Mismatch Amplification Mutation Assays) were designed (Birdsell et al., [@B6]) targeting at least two randomly selected SNPs on each major branch (Table [2](#T2){ref-type="table"}). Changes to primer base composition are detectable in melt-curve analysis, allowing differential fluorescence to determine the allele. Using DNA from the 34 isolates from Omani livestock, we performed Real-Time PCR with SYBR Green incorporation on an Applied Biosystems 7900HT Fast Real-Time PCR system. We ran 5 μL reactions with 1 μL DNA standardized to 2 ng/μL, when possible, and 4 μL of PCR reagents. Final concentration per reaction was 1X ABI SYBR Green Universal PCR Master Mix, and 0.15 μM each of the derived MAMA primer, ancestral MAMA primer, and reverse consensus primer. In practice this converts to 1.28 μL molecular grade water, 2.5 μL of 2X Universal PCR Master mix, and 0.08 μL each of the three primers at 10 μM each. In melt-MAMA reactions, the derived or ancestral primer containing the SNP allele more effectively amplifies in a competing reaction. Thermo-cycling conditions were as follows: initial UNG activation of 2 min at 50°C, a hot start of 10 min at 95°C, followed by 40 PCR cycles of 15 s at 95°C for denaturation and 1 min at 60°C for annealing, and a final stage of 15 s at 95°C, 15 s at 60°C, and 15 s at 95°C. Alleles were readily distinguished by the melting step and were confirmed with positive controls for each allele state (Birdsell et al., [@B6]). The SNP genotyping assays were run on all 34 Omani livestock *B. melitensis* samples.

###### 

Assay design parameters for primer sets targeting 6 major branches of *Brucella melitensis*.

  **Branch**   **Reference genome position**   **SNP state**   **Primer**   **5′--\>3′**                              **State**   **% GC content**   **Primer Tm°C**   **Primer length (bp)**   **Amplicon length (bp)**   **Amplicon Tm°C**
  ------------ ------------------------------- --------------- ------------ ----------------------------------------- ----------- ------------------ ----------------- ------------------------ -------------------------- -------------------
  1            6028                            A/G             F1           ggggcggggcggggcCCGGCGAAATGCTGGCGaTa       D           60                 56                20                       42                         74
                                                               F2           CCGGCGAAATGCTGGCGtTg                      A           65                 58                20                                                  
                                                               C            GATGCGTATAGCCTTCCTCGC                     C           57                 56                21                                                  
  2            1169400                         A/G             F1           ggggcggggcggggcGCAGAAGCGCACTGGAATATgTa    D           48                 55                23                       58                         72
                                                               F2           GCAGAAGCGCACTGGAATATaTg                   A           48                 55                23                                                  
                                                               C            GGTTAAAATATGCTGTGCTGTACAGGG               C           44                 58                27                                                  
  3            1127740                         C/T             F1           ggggcggggcggggcCGTAACAGGCAGCAATCTGCAgTc   D           54                 59                24                       50                         73
                                                               F2           CGTAACAGGCAGCAATCTGCAcTt                  A           50                 57                24                                                  
                                                               C            TCAAACTATTAAGGGGTCGTTCCGG                 C           55                 54                25                                                  
  4            870030                          T/C             F1           ggggcggggcggggcCGCGGGTTTCTTCATCCAGAAtGt   D           63                 55                24                       51                         75
                                                               F2           CGCGGGTTTCTTCATCCAGAAgGc                  A           58                 61                24                                                  
                                                               C            GCCGGGGCGACATCATAGATCG                    C           64                 60                22                                                  
  5            842276                          T/C             F1           ggggcggggcggggcGCGCCTCCTGCTGCCTcCt        D           74                 60                19                       49                         72
                                                               F2           GCGCCTCCTGCTGCCTaCc                       A           74                 59                29                                                  
                                                               C            GAATCATTATCGTTCAGATACATAAAGCC             C           34                 56                29                                                  
  10           747768                          A/C             F1           ggggcggggcggggcGGCGCGGAGCCATATTGgAa       D           60                 56                20                       55                         73
                                                               F2           GGCGCGGAGCCATATTGcAc                      A           65                 58                20                                                  
                                                               C            CCTTTAACCCTAGCAATTGGAGGAAC                C           46                 58                26                                                  

*Reference genome is 16 M (NCBI RefSeq accession numbers [NC_003317.1](NC_003317.1) and [NC_003318.1](NC_003318.1)). Branch numbers correspond to branch labels in Figure [1](#F1){ref-type="fig"}. State column refers to Derived (D), Ancestral (A), and Consensus (C), state of the SNP targeted by that specific primer. Tm is the melting temperature for the primers or the amplicon*.

We also performed MLVA on the 15 camel isolates following the methods of Huynh et al. ([@B16]). Briefly, this is a 15 locus VNTR panel that uses four multiplex PCRs with fluorescently labeled forward primers (6-FAM, NED, PET, or VIC) and unlabeled reverse primers. Fragment sizes for each locus were visualized by capillary electrophoresis on an ABI 3130 Genetic Analyzer and converted to a repeat number corresponding to each fragment size using the LIZ 1200 size standard in GeneMapper version 4.0. As detailed by Tiller et al. ([@B43]), the MLVA approach we used compares favorably to the more widely used MLVA approach (Le Fleche et al., [@B22]), although the latter has an expansive database of MLVA genotypes (<http://mlva.u-psud.fr/brucella/>).

Results {#s3}
=======

In this work, we used SNPs discovered in whole genome comparisons to develop multiple SNP assays that distinguish six major branches in *B. melitensis*. We present details on the assays that provided the greatest peak separation for SNPs found on each branch (Table [2](#T2){ref-type="table"}). Of particular interest to this study was the phylogenetic placement of isolates from Omani livestock; all 34 of these Omani isolates are part of the clade on the assay branch 2 (Figure [1](#F1){ref-type="fig"}). The finding that Omani livestock samples all came from a distinct branch in the *B. melitensis* phylogeny indicates that these animals all contain relatively closely related isolates from a single lineage.

SNP analyses indicate that all of our *B. melitensis* isolates from Omani camels belong to a distinct clade that also contains isolates originating in Africa (Nigeria, Chad, Tanzania). This key finding was unexpected, as one would predict that isolates from the Arabian Peninsula would be part of the E. Mediterranean lineage that predominates the region (Gyuranecz et al., [@B14]). Thus, SNP analysis indicates that Omani livestock isolates are part of a group of *B. melitensis* that is related to isolates from Africa and distantly related to most other isolates from the Middle East. Moreover, it suggests that the lineages of *B. melitensis* in Egypt and probably throughout much of N. Africa are distinct from most strains from the rest of the Middle East. Our SNP assays also identify two major groups within the E. Mediterranean clade, branches 4 and 5, suggesting substructure within this group. Interestingly, the African clade isolates are more closely related to isolates from the Americas clade than the E. Mediterranean clade in this rooted tree, a pattern not seen in MLVA (Gyuranecz et al., [@B14]), likely due to the higher resolution of whole genome sequencing.

MLVA results were compared to our database of MLVA genotypes from the Middle East (Huynh et al., [@B16]; Tiller et al., [@B43]). We utilized all MLVA genotypes from the African clade and a representative sample of genotypes from the E. Mediterranean and Americas clades (Table [3](#T3){ref-type="table"}). A fourth lineage, W. Mediterranean, is not part of our collection, nor was it detected in our sampling so was not included in our phylogeny. The W. Mediterranean clade is largely limited to Italy (Garofolo et al., [@B10]) but does occur in other countries, including along the Mediterranean (Lounes et al., [@B23]). Low DNA quality prevented us from running MLVA on the 12 other animal isolates from Oman but this DNA was still of sufficient quality to SNP-based analysis on Real-Time PCR due to the smaller amplicons sizes and higher sensitivity of these Real-Time assays (Birdsell et al., [@B6]). The 10 most stable of the 15 Variable Number Tandem Repeat (VNTR) loci were used in our analyses (VNTRs: 1, 3, 7, 14, 16, 20, 21, 25 27, 28). Limiting VNTR loci to the most stable markers, or placing greater weighting on these markers, is a common practice in *Brucella* MLVA (e.g., Al Dahouk et al., [@B3]). Such a practice reduces homoplasy and allows for understanding deeper phylogenetic relationships but potentially sacrifices more recent epidemiological connections (Keim et al., [@B20]); this potential loss of resolution was not a concern for our study because we were focused on these deeper connections.

###### 

MLVA-10 genotypes for 221 isolates of *Brucella melitensis* from the Middle East. Isolates from additional regions added for context.

  **Sample ID**     **Country**    **Host**           **Lineage**    **VNTR locus**                                                   
  ----------------- -------------- ------------------ -------------- ---------------- ----- ----- ----- ----- ----- ----- ----- ----- -----
  1652              Afghanistan    goat               E. Med.        100              123   191   267   225   320   322   389   453   496
  1657              Afghanistan    sheep              E. Med.        100              123   215   219   225   308   322   413   453   496
  1761              Afghanistan    sheep              E. Med.        100              123   191   267   225   320   322   389   453   496
  2011756220        Afghanistan    human              E. Med.        100              123   191   202   225   320   322   381   453   496
  2011756221        Afghanistan    goat               E. Med.        100              123   191   219   225   320   322   381   453   496
  2013004349        Afghanistan    human              E. Med.        100              123   191   235   225   320   322   381   453   496
  25                Afghanistan    human              Americas       100              123   174   227   258   327   370   373   453   496
  27                Afghanistan    human              Americas       100              123   174   227   258   327   370   373   453   496
  29                Afghanistan    human              Americas       100              123   174   227   258   327   370   373   453   496
  31                Afghanistan    human              Americas       100              123   174   227   258   327   370   373   453   496
  2008010924        Bosnia         human              E. Med.        100              123   208   227   225   320   386   438   453   496
  2011756294        Bosnia         human              E. Med.        100              123   232   251   225   320   354   413   453   496
  2008018505        Egypt          human              Africa         100              123   215   219   250   320   403   413   441   496
  E1-ABS-9258       Egypt          human              Africa         100              123   215   300   250   316   370   397   441   496
  E10-ALX-0769      Egypt          human              Africa         100              123   184   194   250   316   386   446   441   496
  E11-ASW-0309      Egypt          human              Africa         100              123   215   227   250   316   419   389   441   496
  E12-ABS-9517      Egypt          human              Africa         100              123   191   219   250   316   394   430   441   496
  E13-FAY-9671      Egypt          human              Africa         100              123   223   235   250   316   394   397   441   496
  E14-BEN-0044      Egypt          human              Africa         100              123   208   314   250   316   394   397   441   496
  E15-SHB-10112     Egypt          human              Africa         100              123   174   235   250   316   419   430   441   496
  E16-ZAG-0133      Egypt          human              Africa         100              123   215   243   250   316   419   405   441   496
  E17-PRS-0241      Egypt          human              Africa         100              123   199   235   250   316   460   413   441   496
  E18-SHB-1482      Egypt          human              Africa         100              123   215   243   250   316   403   430   441   496
  E19-ALX-0996      Egypt          human              Africa         100              123   199   219   250   316   444   413   441   496
  E2-MAL-9273       Egypt          human              Africa         100              123   208   219   250   316   411   430   441   496
  E20-MAL-0941      Egypt          human              Africa         100              123   215   227   250   316   435   405   441   496
  E21-ABS-10208     Egypt          human              Africa         100              123   208   211   250   316   330   381   441   496
  E22-QEN-0166      Egypt          human              Africa         100              123   223   267   250   316   386   397   441   496
  E23-ABS-10654     Egypt          human              Africa         100              123   199   243   250   316   338   381   441   496
  E24-ALX-1734      Egypt          human              Africa         100              123   199   243   250   316   354   405   441   496
  E25-MAL-1462      Egypt          human              Africa         100              123   191   235   250   316   419   413   441   496
  E26-SHB-2267      Egypt          human              Africa         100              123   208   243   250   316   378   430   441   496
  E27-ALX-2000      Egypt          human              E. Med.        95               123   215   219   217   316   322   413   393   496
  E28-SHB-2340      Egypt          human              Africa         95               123   191   227   250   316   322   405   393   496
  E29-ASW-1381      Egypt          human              Africa         100              123   199   211   250   316   403   381   441   496
  E3-SHB-0395       Egypt          human              Africa         100              123   199   219   250   316   346   405   441   496
  E30-AST-0977      Egypt          human              Africa         100              123   199   267   258   316   394   397   441   496
  E31-AST-1030      Egypt          human              E. Med.        95               123   215   243   217   316   322   381   425   496
  E32-QEN-0364      Egypt          human              Africa         100              123   215   227   250   316   403   373   441   496
  E33-ALX-2307      Egypt          human              Africa         100              123   199   267   250   316   419   389   441   496
  E34-MAL-1821      Egypt          human              Africa         100              123   191   251   250   316   370   413   441   496
  E35-SHB-2580      Egypt          human              Africa         100              123   208   235   250   316   452   430   441   496
  E36-ALX-2198      Egypt          human              Africa         100              123   191   243   250   316   435   397   441   496
  E37-QEN-0388      Egypt          human              Africa         100              123   223   243   250   316   411   373   441   496
  E38-ASW-1553      Egypt          human              Africa         100              123   199   251   250   316   394   389   441   496
  E39-ALX-0077      Egypt          human              Africa         100              123   208   283   250   316   428   389   441   496
  E4-QEN-0062       Egypt          human              Africa         100              123   223   219   250   316   386   373   441   496
  E40-ABS-9024      Egypt          human              Africa         100              123   208   211   250   316   419   389   441   496
  E41-SOH-9085      Egypt          human              Africa         100              123   248   243   250   316   346   381   441   496
  E42-SOH-0002      Egypt          human              Africa         100              123   248   243   250   316   346   381   441   496
  E43-SHB-9203      Egypt          human              Africa         100              123   199   227   250   316   419   397   441   496
  E44-SHB-9204      Egypt          human              Africa         100              123   208   211   258   316   419   397   441   496
  E45-SHB-0492      Egypt          human              Africa         100              123   191   227   250   316   468   405   441   496
  E46-SHB-0496      Egypt          human              Africa         100              123   191   267   250   316   403   430   441   496
  E47-ZAG-0127      Egypt          human              Africa         100              123   199   235   258   316   444   397   441   496
  E48-MAL-0966      Egypt          human              Africa         100              123   208   219   250   316   403   397   441   496
  E49-MAL-0958      Egypt          human              Africa         100              123   215   243   250   316   419   397   441   496
  E5-ABS-9281       Egypt          human              Africa         100              123   191   283   250   316   419   446   441   496
  E50-SHB-1580      Egypt          human              Africa         100              123   199   227   250   316   346   430   441   496
  E51-SHB-1572      Egypt          human              Africa         100              123   191   243   250   316   354   430   356   496
  E52-FAY-10244     Egypt          human              Africa         100              123   191   291   258   316   370   389   441   496
  E53-FAY-10257     Egypt          human              Africa         100              123   191   219   258   316   394   389   441   496
  E54-BEN-0182      Egypt          human              Africa         100              123   191   227   250   316   452   381   441   496
  E55-MAL-1111      Egypt          human              Africa         100              123   215   227   250   316   444   381   441   496
  E56-SHB-2081      Egypt          human              Africa         100              123   191   194   250   316   394   389   441   496
  E57-ASW-10776     Egypt          human              Africa         100              123   208   202   250   316   411   389   441   496
  E58-SHB-2177      Egypt          human              Africa         100              123   199   259   250   316   394   397   441   496
  E59-ASW-1220      Egypt          human              Africa         100              123   208   259   250   316   386   405   441   496
  E6-SHB-0407       Egypt          human              Africa         100              123   199   267   250   316   403   405   441   496
  E60-ASW-1237      Egypt          human              Africa         100              123   199   211   250   316   403   381   441   496
  E61-AST-1053      Egypt          human              Africa         100              123   208   235   258   316   394   397   441   496
  E62-AST-1008      Egypt          human              Africa         100              123   208   194   258   316   394   397   441   496
  E63-AST-1085      Egypt          human              Africa         100              123   199   243   258   316   403   397   441   496
  E64-ALX-4         Egypt          human              Africa         100              123   191   202   250   316   403   397   441   496
  E65-ALX-107       Egypt          human              Africa         100              123   215   235   250   316   435   389   441   496
  E66-MAL-104       Egypt          human              Africa         100              123   199   259   250   316   468   397   441   496
  E67-MAL-135       Egypt          human              Africa         100              123   208   243   250   316   460   381   441   496
  E68-ABS-52        Egypt          human              Africa         100              123   208   235   258   316   362   389   441   496
  E69-ABS-157       Egypt          human              Africa         100              123   199   235   250   316   428   413   441   496
  E7-ALX-0404       Egypt          human              Africa         100              123   208   283   250   316   378   397   441   496
  E70-ABS-49        Egypt          human              Africa         100              123   199   251   250   316   394   446   441   496
  E71-AFI-ABS-134   Egypt          human              Africa         100              123   215   211   217   316   452   413   441   496
  E72-MAL-305       Egypt          human              Africa         100              123   208   219   250   316   378   430   441   496
  E73-ALX-458       Egypt          human              Africa         100              123   199   259   250   316   386   389   441   496
  E74-MAL-293       Egypt          human              Africa         100              123   208   276   250   316   370   413   441   496
  E75-ABS-93        Egypt          human              Africa         100              123   199   235   250   316   444   413   441   496
  E76-ABS-211       Egypt          human              Africa         100              123   199   235   258   316   403   389   405   496
  E77-ALX-467       Egypt          human              Africa         100              123   199   235   250   316   370   389   441   496
  E78-ALX-468       Egypt          human              Africa         100              123   208   211   258   316   386   397   441   496
  E79-MAL-335       Egypt          human              Africa         100              123   215   211   250   316   386   413   441   496
  E8-SHB-0676       Egypt          human              Africa         100              123   191   259   250   316   419   389   441   496
  E80-MAL-353       Egypt          human              Africa         100              123   199   219   250   316   394   389   441   496
  E81-ALX-535       Egypt          human              Africa         100              123   199   259   250   316   394   389   441   496
  E82-ALX-532       Egypt          human              Africa         100              123   191   211   258   316   411   381   441   496
  E83-ASW-84        Egypt          human              Africa         100              123   199   251   250   316   378   381   441   496
  E9-FAY-9445       Egypt          human              Africa         100              123   199   267   250   316   419   389   441   496
  3000409149        Ethiopia       human              Americas       100              123   215   194   258   327   362   381   453   496
  2010022407        Greece         human              E. Med.        100              123   215   235   225   320   370   405   453   498
  2006012884        Iran           human              E. Med.        100              123   208   243   225   320   322   397   453   496
  2006012885        Iran           human              E. Med.        100              123   208   243   225   320   322   397   453   496
  2010022413        Iran           human              Americas       100              123   174   219   258   320   362   405   453   496
  3000027166        Iran           human              E. Med.        100              123   199   227   225   320   322   413   453   496
  2004017806        Iraq           human              E. Med.        100              123   191   219   225   320   322   413   453   496
  2008724248        Iraq           human              E. Med.        100              123   215   211   225   320   338   430   453   496
  2012005317        Iraq           human              E. Med.        100              123   191   251   225   320   362   381   453   496
  2012017239        Iraq           human              Intermediate   100              123   184   211   225   320   386   389   453   496
  2013746956        Iraq           human              E. Med.        100              123   208   219   225   320   354   389   453   496
  2013833054        Iraq           human              Intermediate   100              123   199   211   225   320   346   389   453   496
  2014001382        Iraq           human              Intermediate   100              123   199   194   225   320   386   397   453   496
  2014001698-2      Iraq           human              Intermediate   100              123   199   194   225   320   386   397   453   496
  2014001698-3      Iraq           human              Intermediate   100              123   199   194   225   320   386   397   453   496
  1988035349        Israel         human              Africa         100              123   208   211   225   320   378   389   441   496
  1988035350        Israel         human              E. Med.        100              123   191   235   225   320   362   405   453   496
  1988035351        Israel         human              E. Med.        100              123   199   219   225   320   386   389   453   496
  1988035352        Israel         human              E. Med.        100              123   199   219   225   320   386   381   453   496
  1988035353        Israel         human              E. Med.        100              123   199   219   225   320   386   389   453   496
  1988035354        Israel         human              Africa         100              123   208   202   225   320   378   389   441   496
  1988035355        Israel         human              E. Med.        100              123   191   235   225   320   362   405   453   496
  1988035356        Israel         human              E. Med.        100              123   191   235   225   320   362   405   453   496
  1988035357        Israel         human              E. Med.        100              123   191   235   225   320   362   405   453   496
  1988035358        Israel         human              E. Med.        100              123   199   219   225   320   386   389   453   496
  1988035359        Israel         human              E. Med.        100              123   191   235   225   320   362   405   453   496
  1988035360        Israel         human              Intermediate   100              123   199   211   225   320   386   389   453   496
  1988035361        Israel         human              Africa         100              123   199   211   225   320   378   389   453   496
  1988035362        Israel         human              Intermediate   100              123   199   211   225   320   386   389   453   496
  2014002005        Israel         human              E. Med.        100              123   208   227   225   320   322   389   453   496
  2002018756        Italy          human              Africa         100              123   199   243   250   320   394   405   441   496
  2003018302        Italy          human              Africa         100              123   199   243   250   320   394   405   441   496
  3000015492        Jordan         human              E. Med.        100              123   223   202   225   320   362   373   453   496
  3000015245        Kazakhstan     human              E. Med.        100              123   199   251   225   320   322   405   453   496
  2012016719        Lebanon        human              E. Med.        100              123   191   276   225   320   378   389   453   496
  L1                Libya          human              Africa         100              123   199   267   258   316   394   397   441   496
  2011756293        Mexico         human              Americas       100              123   174   202   250   320   362   381   453   496
  2012005445        Mexico         human              Americas       100              123   174   235   250   327   362   389   453   496
  2013005190        Mexico         human              Africa         100              115   184   243   241   320   403   373   441   478
  2013005440        Mexico         human              Americas       100              123   174   227   250   327   354   389   453   496
  2013007561        Mexico         human              Americas       100              123   174   227   241   327   354   389   453   496
  2013746874        Mexico         human              Americas       100              123   174   235   241   327   346   389   453   496
  2014001235        Mexico         human              Americas       100              123   174   227   250   320   354   413   453   496
  2014001327        Mexico         human              Americas       100              123   174   202   241   327   362   389   453   496
  3000015243        Mexico         human              Americas       100              123   174   227   250   327   354   381   453   496
  3000015269        Mexico         human              Americas       100              123   174   227   241   327   346   389   453   496
  3000023891        Mexico         human              Americas       100              123   174   219   250   327   362   381   453   496
  3000023892        Mexico         human              Americas       100              123   174   235   241   327   346   389   453   496
  3000023893        Mexico         human              Americas       100              123   174   219   250   327   362   381   453   496
  3000023969        Mexico         human              Americas       100              123   174   235   250   327   394   413   453   496
  3000026676        Mexico         human              Americas       100              123   174   202   250   327   338   389   453   496
  3000050553        Mexico         human              Americas       100              123   174   211   258   327   362   373   453   496
  3000050738        Mexico         human              Americas       100              123   174   211   258   327   362   373   453   496
  3000404015        Mexico         human              Americas       100              123   174   267   250   327   370   373   453   496
  3000404142        Mexico         human              Americas       100              123   174   227   250   327   354   405   453   496
  3000407000        Mexico         human              Americas       100              123   174   219   250   327   354   397   453   496
  3000496880        Mexico         human              Americas       100              123   174   211   250   327   362   381   453   496
  3000496881        Mexico         human              Americas       100              123   174   211   250   327   362   381   453   496
  BTRU \#1501       Mexico         human              Americas       100              123   174   227   241   327   394   381   453   496
  MEX349            Mexico         human              Americas       100              124   175   219   265   325   362   397   453   493
  MEX350            Mexico         human              Americas       100              124   175   219   249   325   387   373   453   493
  MEX351            Mexico         human              Americas       100              124   175   219   249   325   386   373   453   493
  MEX352            Mexico         human              Americas       100              124   175   178   241   325   362   405   453   493
  Bruc-VRC-1        Oman           camel              Africa         101              124   191   202   258   318   380   389   440   491
  Bruc-VRC-10       Oman           camel              Africa         101              124   199   186   250   318   348   374   440   491
  Bruc-VRC-11       Oman           camel              Africa         101              124   199   186   250   316   348   374   440   492
  Bruc-VRC-12       Oman           camel              Africa         101              124   199   259   250   316   348   374   440   491
  Bruc-VRC-13       Oman           camel              Africa         101              124   207   235   250   318   348   413   440   491
  Bruc-VRC-14       Oman           camel              Africa         101              243   199   124   250   317   348   413   440   491
  Bruc-VRC-15       Oman           camel              Africa         101              124   191   226   258   316   356   397   440   491
  Bruc-VRC-2        Oman           camel              Africa         101              123   191   235   250   318   340   405   440   491
  Bruc-VRC-3        Oman           camel              Africa         101              124   191   227   258   318   356   398   440   492
  Bruc-VRC-4        Oman           camel              Africa         101              124   191   210   258   318   404   382   440   491
  Bruc-VRC-5        Oman           camel              Africa         101              124   199   210   250   301   397   389   440   491
  Bruc-VRC-6        Oman           camel              Africa         101              124   207   227   258   318   356   390   440   491
  Bruc-VRC-7        Oman           camel              Africa         101              124   199   226   258   318   356   389   439   491
  Bruc-VRC-8        Oman           camel              Africa         101              124   207   227   258   317   356   389   439   491
  Bruc-VRC-9        Oman           camel              Africa         101              124   207   227   258   318   356   390   439   492
  2010023909        Qatar          human              E. Med.        100              123   191   194   225   320   370   405   453   496
  2010023910        Qatar          human              E. Med.        100              123   199   227   225   320   322   405   464   496
  2013002770        Qatar          human              Africa         100              123   215   211   250   320   354   397   441   496
  Q1-AT-BR-001      Qatar          human              Africa         100              123   215   202   250   316   378   405   441   496
  Q10-AT-BR-010     Qatar          human              Africa         100              123   208   211   233   316   322   397   464   496
  Q11-AT-BR-011     Qatar          human              E. Med.        100              123   191   227   233   316   346   413   453   496
  Q12-AT-BR-012     Qatar          human              E. Med.        100              123   208   219   233   316   322   389   453   496
  Q13-AT-BR-013     Qatar          human              Africa         100              123   215   251   250   316   419   389   441   496
  Q14-AT-BR-014     Qatar          human              E. Med.        100              123   191   227   233   316   378   389   453   496
  Q15-AT-BR-015     Qatar          human              Africa         100              123   199   235   233   316   370   397   453   496
  Q16-AT-BR-016     Qatar          human              E. Med.        100              123   191   227   233   316   322   389   464   496
  Q17-AT-BR-017     Qatar          human              Africa         100              123   184   267   233   316   378   381   441   496
  Q2-AT-BR-002      Qatar          human              Africa         100              123   199   235   233   316   338   397   453   496
  Q3-AT-BR-003      Qatar          human              Africa         100              123   215   202   217   316   370   405   441   496
  Q4-AT-BR-004      Qatar          human              E. Med.        100              123   191   194   233   316   346   413   453   496
  Q5-AT-BR-005      Qatar          human              Africa         100              123   215   202   217   316   370   405   441   496
  Q6-AT-BR-006      Qatar          human              Africa         100              123   199   235   258   316   378   397   441   496
  Q7-AT-BR-007      Qatar          human              Africa         100              123   232   186   258   316   444   457   441   496
  Q8-AT-BR-008      Qatar          human              E. Med.        100              123   199   227   233   316   322   405   453   496
  Q9-AT-BR-009      Qatar          human              E. Med.        100              123   191   235   233   316   322   389   464   496
  2011756247        reference      type strain 16 M   Americas       100              123   174   227   233   327   346   373   453   496
  2011756235        reference      type strain 63/9   E. Med.        100              123   215   267   225   308   322   389   453   496
  2010022409        reference      Rev-1 strain       Americas       100              123   174   227   258   327   370   381   453   496
  2011019381        Saudi Arabia   human              E. Med.        100              123   232   276   225   320   322   413   464   496
  2011756376        Saudi Arabia   human              E. Med.        100              123   208   235   225   320   322   405   464   496
  2013008314        Saudi Arabia   human              E. Med.        100              123   199   243   225   320   322   397   453   496
  2013008432        Saudi Arabia   human              E. Med.        100              123   199   227   225   320   322   381   453   496
  2013012794        Saudi Arabia   human              E. Med.        100              123   215   235   225   320   322   422   464   496
  2013016252        Saudi Arabia   human              E. Med.        100              123   199   227   225   320   322   381   453   496
  2014003496        Saudi Arabia   human              E. Med.        100              123   223   227   225   320   322   413   464   496
  3000015437        Saudi Arabia   human              E. Med.        100              123   191   219   225   320   322   389   453   496
  3000015487        Saudi Arabia   human              Americas       100              123   199   227   225   327   386   389   453   496
  3000015489        Saudi Arabia   human              E. Med.        100              123   208   235   225   320   322   389   453   496
  F4018             Saudi Arabia   human              E. Med.        100              124   207   219   225   317   322   389   452   492
  3000358781        Senegal        human              Americas       100              123   174   202   241   320   330   381   453   496
  2011756228        Somalia        human              E. Med.        95               123   191   243   225   327   338   389   453   496
  2013746792        Somalia        human              E. Med.        95               123   191   243   225   327   338   389   453   496
  2013746793        Somalia        human              E. Med.        95               123   191   243   217   327   362   381   453   496
  2004017844        Syria          human              Africa         100              123   184   211   225   324   338   397   441   498
  2004017845        Syria          human              E. Med.        100              123   199   227   225   320   370   405   441   496
  2008724251        Syria          human              Americas       100              123   174   227   250   327   370   381   453   496
  2010724533        Syria          human              E. Med.        100              123   208   235   225   320   362   397   453   496
  2013746965        Syria          human              Americas       100              123   174   227   258   327   370   373   453   496
  2006006287        Turkey         human              Africa         100              123   184   211   233   316   386   430   441   496
  2009027624        Turkey         human              E. Med.        100              123   191   202   225   320   346   397   453   496
  2013008341        UAE            human              E. Med.        100              123   199   243   225   320   354   413   356   496
  3000015259        Uzbekistan     human              E. Med.        100              123   199   243   225   320   322   381   453   496

*Country refers to the suspected origin of brucellosis infection although human travel and trade in contaminated animal products may obscure the true origin. Lineage refers to the MLVA branch from Figure [2](#F2){ref-type="fig"}; seven isolates were classified as Intermediate due to genotypes not assigned to one of the three main lineages we investigated (Africa, Americas, E. Mediterranean). VNTR loci follow the numbering of Huynh et al. ([@B16]). Strains not definitively assigned to a lineage were considered Intermediate*.

Three distinct lineages of *B. melitensis* were found in our sampling, consistent with geographic groupings of Americas, E. Mediterranean, and Africa clades. Al Dahouk et al. ([@B3]) first identified the Americas and E. Mediterranean clades but used a different MLVA genotyping scheme (Le Fleche et al., [@B22]). Subsequent work by Gyuranecz et al. ([@B14]), identified another lineage, the Africa clade. This consistency between the two MLVA schemes, as well as support from whole genome analyses, suggests that either scheme is capable of identifying these major lineages although differentiation of the Africa clade is more pronounced with the Huynh et al. ([@B16]) MLVA scheme. VNTR genotypes were compared using minimum spanning trees in Phyloviz 2.0 (Nascimento et al., [@B29]).

Using MLVA genotyping, the VNTR diversity we observed in these 15 camel isolates divide into 3--6 distinct lineages, depending on clustering criteria (Figure [2](#F2){ref-type="fig"}). Use of all 15 MLVA loci gave similar overall patterns (data not shown). All camel isolates from Oman, except for one highly similar to a human isolate from Qatar (Q7), are closely related to samples from human patients from Egypt, typically differing from each other by only 1--3 VNTR mutations; indicating that highly related strains circulating across the region in both livestock and humans. Our MLVA results also support the SNP analyses that the Omani camel isolates have greatest similarity to *B. melitensis* isolates from North Africa. Omani camel isolates are related to isolates originating from humans in Egypt, sometimes separated by only one VNTR repeat. Epidemiological trace back may allow for identification of these potential animal to human transmission events. We also note the presence of African lineage isolates in other countries in the region, including Libya, Israel, Syria, Turkey, and Qatar.

![Minimum spanning tree of 221 *Brucella melitensis* isolates based on MLVA-10 genotyping. Country of origin for isolates from the Middle East is represented by the colored circles. Additional isolate details are found in Table [3](#T3){ref-type="table"}.](fmicb-08-02702-g0002){#F2}

Discussion {#s4}
==========

Our study highlights the presence of a unique lineage of *B. melitensis* in the Middle East, provides assays to quickly identify the strain types circulating and causing animal and human brucellosis in the region, and suggests that substantial diversity remains to be uncovered in Africa. The SNP assays we designed, particularly those for branch 2, allow for rapid identification of African lineage strains and thus can be used to focus on finding new genetic variation among this poorly sampled group. When samples are identified as part of the African lineage, MLVA can then be utilized for higher resolution analyses, such as understanding the relationships among African isolates and for epidemiological investigations.

SNP genotyping
--------------

The SNP-based results from the whole genome analyses and SNP genotyping support the finding that an African lineage of *B. melitensis* exists in the Arabian Peninsula (e.g., Oman and Qatar), and other nearby countries such as Israel, Turkey, and Syria. Although the African lineage appears to be uncommon elsewhere, it nonetheless has been introduced into many Middle Eastern countries. The two SNP assays specific for branch 2 can quickly identify isolates that are part of this unique African lineage, allowing for a determination of the spread of this clade.

We emphasize that the African clade is a phylogenetic assignment and not a geographic one, and that not all isolates from Africa will be a part of this clade. Accordingly, isolates from Algeria in western North Africa were predominantly from the W. Mediterranean clade (Lounes et al., [@B23]), suggesting a connection to Europe (especially Italy) rather than the rest of North Africa or other parts of the Middle East. Our SNP findings, and those of Georgi et al. ([@B11]), highlight the power of whole genome analyses and this genomic approach is able to clearly distinguish isolates from the African and E. Mediterranean clades as evolutionarily distinct lineages.

MLVA genotyping
---------------

The MLVA groupings show broad and consistent geographic representations of MLVA types from the Americas, E. Mediterranean clade (consisting primarily of West/Central Asia and Middle Eastern isolates), and Africa. Although this method uses different loci than SNP approaches, these groupings match those from the SNP-based genotyping. Using the MLVA method of Le Fleche et al. ([@B22]), *B. melitensis* isolates from the United Arab Emirates from camels, cattle, and a goat had genotypes from the E. Mediterranean clade but also contained isolates from four camels and a gazelle from the African clade (Gyuranecz et al., [@B14]). Indeed, the expectation for *B. melitensis* isolates collected from humans or livestock from the Arabian Peninsula and most of the Middle East is membership in the E. Mediterranean clade (Al Dahouk et al., [@B3]; Kattar et al., [@B18]; Kilic et al., [@B21]). MLVA and whole genome analyses indicate that the E. Mediterranean clade is the principal lineage in the region, continuing from the Middle East along the Mediterranean and into and throughout Asia (Jiang et al., [@B17]; Tan et al., [@B41]; Tay et al., [@B42]). Whole genome comparisons from brucellosis patients infected in the Middle East support this predominance of the E. Mediterranean clade but also identify three isolates of Somali origin from an Africa clade (Georgi et al., [@B11]). Despite its broad sampling and thousands of genotypes for *B. melitensis*, the MLVA database (<http://mlva.u-psud.fr/brucella/>) contains few representatives from North Africa so it appears to be currently missing much of this genetic diversity. We encourage researchers using the Le Fleche MLVA scheme to genotype samples from this region for a better global understanding of this lineage, after first using our SNP-based assays to identify this clade.

Resolving apparent inconsistencies
----------------------------------

Our findings challenge common approaches used in *Brucella* epidemiology. While we detail our results from traditional phenotyping approaches, these data are typically not informative for understanding the genetic relationships of isolates within *B. melitensis*. For example, distinguishing the three biovars of *B. melitensis* provides limited resolution when attempting to establish epidemiological links between outbreaks; likely due to the limited association between genotype and phenotype (biovar) in this species (Whatmore et al., [@B47]). In fact, isolates from biovars 1, 2, and 3 can be closely related genetically (e.g., Jiang et al., [@B17]) and isolates from the same biovar can be distantly related and from evolutionarily distinct clades (e.g., De Massis et al., [@B7]). Apparent discrepancies also occur for the country of origin for some isolates; a handful of SNP-based and MLVA genotypes appear to not match the expected clade corresponding to the region. For example, in the SNP phylogeny an isolate from Poland is in the Americas clade, and samples from the USA are in the E. Mediterranean clade. Such discordance is expected. First, as mentioned previously these groupings are phylogenetic assignments and should not be misconstrued as geographic origins. In addition, epidemiological histories of various strains are not always precisely known and the country names may indicate where the isolate was identified and not necessarily the country of origin. Finally, international travel of patients infected with brucellosis or movement of infected animals may potentially obscure the country of origin unless detailed epidemiological data are available (Al Dahouk et al., [@B4]; Garofolo et al., [@B10]; De Massis et al., [@B7]; Georgi et al., [@B11]).

Brucellosis management
----------------------

Disease management approaches involving vaccination, treatment with antibiotics, and test-and-slaughter programs for camels can lower disease incidence and even eliminate brucellosis from some farms (Radwan et al., [@B33]; Abbas and Agab, [@B1]; Wernery, [@B45]). Nonetheless, comprehensive elimination of *B. melitensis* in camels from larger regions will require brucellosis management in goats and sheep. Despite calls for the elimination of brucellosis from the Arabian Peninsula for over two decades (Tabbara, [@B40]), the disease persists throughout the region and indeed continues to be a successful pathogen throughout much of world. High prevalence rates in sheep, goats and cattle, and the hundreds of millions of these animals in the region make brucellosis elimination difficult (Refai, [@B34]). Although the economic cost of brucellosis to livestock production in Oman is not well-known, globally the economic burden on both animal and human health is significant and far reaching (Seleem et al., [@B37]). Understanding historic and contemporary movement of animals infected with brucellosis is an important step in improving disease management strategies.

Brucellosis movement
--------------------

The presence of an African lineage from North Africa in the Arabian Peninsula indicates the interconnectedness of livestock in the Greater Middle East, likely due to historical trade and movement between the two regions, although the E. Mediterranean lineage still predominates. Contemporary introductions of *B. melitensis* also appear to occur---the four camels with the African clade genotypes in the United Arab Emirates came from Sudan (Gyuranecz et al., [@B14])---connectedness previously suggested by Wernery ([@B45]). Our results also indicate that not all *B. melitensis* isolates from Africa are part of this "Africa" lineage. For example, some samples from Somalia, Kenya, and Egypt appear to be part of the E. Mediterranean clade and Ethiopian and some Egyptian samples are part of the Americas clade. Moreover, Lounes et al. ([@B23]) identified isolates from the W. Mediterranean clade in the Maghreb region of Algeria. Even less is known from sub-Saharan Africa, where brucellosis is widespread among livestock (Mcdermott and Arimi, [@B24]). Clearly, there is tremendous diversity of *B. melitensis* in Africa, potentially due to many introductions of infected livestock from many regions as well as widespread trade. Additional sampling throughout the African continent is needed to better understand the evolutionary history regarding the origins and spread of *B. melitensis* in the region. Although the African lineage may be more localized than the three widely distributed *B. melitensis* clades, substantial undiscovered diversity likely exists, and as we have discovered in Oman, extends beyond the African continent into new lands that have been connected by trade in camels, goats, and sheep.
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